For instance, IGF-1 activates the IGF-1R/AKT/mTOR survival pathway in CRC, and CXCL-12 promotes EMT and invasion in pancreatic cancer (Li D. et al., 2016; Tommelein et al., 2018). This evidence concerns the gene CXCL12 and familial pancreatic carcinoma.